Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare

► The alliance between the German Cancer Research Center and Bayer HealthCare is presented - an innovative partnership model between industry and academia. ► The model is based on complementary expertise, true collaboration and sharing of risks and rewards. ► Concrete measures based on the RESOLVE model used to promote the collaboration and generation of value for both partners are described. ► Key Success Factors and common learnings for academic-industrial alliances are extracted and presented.